Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.39
-0.04 (-0.90%)
At close: Aug 15, 2025, 2:35 PM

Vanda Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-14.74 96.51 66.49 26.29
PEG Ratio
0.02 -1.6 -0.81 0.66
PS Ratio
1.40 1.26 1.64 3.24
PB Ratio
0.52 0.44 0.79 1.73
P/FCF Ratio
-17.14 19.50 13.33 13.69
P/OCF Ratio
-17.68 18.92 13.05 13.57
OCF/S Ratio
-0.08 0.07 0.13 0.24
Debt / Equity Ratio
0.02 0.02 0.02 0.02
Quick Ratio
4.37 4.92 5.67 6.41
Current Ratio
4.39 4.94 5.68 6.43
Asset Turnover
0.30 0.30 0.40 0.45
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.04 n/a 0.01 0.07
Return on Assets
-0.03 n/a 0.01 0.06
Return on Invested Capital
-0.06 -0.01 0.01 0.06
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.94 0.92 0.90 0.90
Net Profit Margin
-0.1 0.01 0.02 0.12
Pretax Profit Margin
-0.12 0.03 0.04 0.16
Operating Profit Margin
-0.2 -0.07 0.02 0.16
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.16 -0.06 0.04 0.17